article thumbnail

Look Out, Investors: Cryptocurrency Values Slide As Warnings Take Off

Xconomy

Bitcoin and other cryptocurrencies have seen dramatic but volatile price surges during the past year. But this month their billions in estimated market value are eroding , amid widening suspicions against one trading platform, a half-billion-dollar heist from another exchange, and an awakened global regulatory community.

Slides 61
article thumbnail

Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More

Xconomy

But in Paris, this cardiologist will be in a conference center, walking an audience through a slide deck packed with Phase 3 data for a new cholesterol-lowering drug, inclisiran. You might be camping, barbecuing, or sleeping on Monday. It’s Labor Day, after all. Inclisiran’s owner, the Medicines Co.,

Slides 80
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Interview with Eugene Cho, Echo Laboratories

socalTECH

Eugene Cho is CEO of San Diego-based Echo Laboratories (www.discover-echo.com), a startup which is developing a new kind of microscope. One, is an upright, traditional looking microscopes, where you look at glass slides. We've created an alternative, a hybrid microscope for the price of one.

article thumbnail

Californians Still Hate Trump, But More Uncertain About Drug Companies

Xconomy

We’re talking of course about next week’s vote on Proposition 61 in California, an attempt to control drug prices in the nation’s most populous state. There has been only a little slide , however, in the state’s projected rejection of GOP presidential candidate Donald Trump.). million) to GlaxoSmithKline ($4.5

Company 40
article thumbnail

Interview with Eugene Cho, Echo

socalTECH

Eugene Cho is CEO of San Diego-based Echo (www.discover-echo.com), a startup which is developing a new kind of microscope. One, is an upright, traditional looking microscopes, where you look at glass slides. We've created an alternative, a hybrid microscope for the price of one.

article thumbnail

Bio Roundup: Jenkins Gets Mad, Bernie Gets His Pen, CRISPR IPO & J-Lo

Xconomy

The staff also crowed over Clinton’s tweet—a reaction last summer to the first revelations about Martin Shkreli’s price gouging —that sent biopharma stocks downhill. His slides are here. The hikes were first reported earlier this month by Adam Feuerstein of The Street. .